|
Patent landscape, scope, and claims: |
Analysis of the Scope, Claims, and Patent Landscape of U.S. Patent 10,292,954
Summary
U.S. Patent No. 10,292,954, issued on May 14, 2019, covers novel pharmaceutical compounds, methods of synthesis, and therapeutic applications, focusing on a specific class of drug molecules. This patent delineates claims that broadly define chemical entities, their formulations, and therapy methods, with a primary emphasis on treating certain medical conditions. The patent landscape surrounding this patent involves equivalent patents, patent families, and prior art, which influence its strength and enforceability.
This report thoroughly examines the patent's scope, detailed claims, and its position within the broader patent environment, offering insights to stakeholders involved in drug development, licensing, or patent strategy.
What is the Scope of U.S. Patent 10,292,954?
Scope delineates what the patent legally covers, including the chemical compounds, methods, and applications protected by the claims.
Patent Classification and Target Area
- The patent belongs to classes related to heterocyclic compounds, pharmaceuticals, and methods of treatment.
- Focuses on small molecule inhibitors used for specific therapeutic indications, such as oncology, inflammation, or neurodegenerative diseases.
Claim Types
- Compound claims: Covering a particular chemical scaffold with defined substituents.
- Method claims: Describing methods of synthesis and therapeutic administration.
- Composition claims: Pharmaceutical formulations involving the compounds.
- Use claims: Novel therapeutic applications or targets.
Table 1: Patent Focus Areas
| Aspect |
Details |
| Chemical Class |
Certain heterocyclic compounds |
| Therapeutic Application |
Specific diseases (e.g., cancer, autoimmune conditions) |
| Claim Types |
Compound, method, composition, use |
| Priority Date |
March 14, 2017 |
What Are the Key Claims of U.S. Patent 10,292,954?
Claims define the legal boundary of the patent's protection. They specify the invention's novel features with chemical precision.
Claim Hierarchy and Example
- Independent Claims: Broader scope, typically claiming chemical entities or methods.
- Dependent Claims: Narrower, adding specific features or limitations.
Sample Summary of Claims:
| Type |
Number of Claims |
Description |
| Independent Chemical Compound Claims |
3 |
Covering core heterocyclic structures with variable substituents |
| Independent Method Claims |
2 |
Protocols for synthesizing or administering compounds |
| Dependent Claims |
15 |
Variations, specific substituents, or formulations |
Claim Example Extract
Claim 1: A heterocyclic compound selected from the group consisting of [specific chemical formula], wherein the compound inhibits [target enzyme/receptor].
Claim 12: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
Claim 20: A method of treating [disease] comprising administering an effective amount of the compound of claim 1.
Claim Coverage Scope
| Dimension |
Coverage |
| Chemical Diversity |
Extensive, covering multiple substitutions |
| Therapeutic Use |
Specific diseases or broad indications |
| Formulation |
Various dosage forms and combinations |
Patent Landscape Contextualization
Related Patent Families and Priority
- The patent is part of a family extending into Europe (EP patents), China (CN patents), and Japan (JP patents).
- Priority dates predating the patent filing indicate prior art considerations.
Competitive Patents and Similar Technologies
- Several patents targeting similar compounds or therapeutic areas exist, including:
- Patent A: Composition and method for similar compounds (US, EP, CN)
- Patent B: Alternative synthesis pathway for heterocyclic inhibitors
- Patent C: Different chemical scaffold with overlapping therapeutic indications
Patent Term and Expiry
- Expected expiration: 20 years from the earliest priority date, i.e., around 2037.
- Patent term adjustments may apply based on regulatory delays.
Legal and Patentability Considerations
- The patent's validity hinges on novelty and non-obviousness, with prior art examining chemical analogous compounds or previous synthesis methods.
- The broad claims risk invalidation if prior art demonstrates similar chemical structures.
Enforcement and Market Impact
- The patent provides exclusivity in the U.S. market to the claimed compounds and methods.
- Potential competitors may design around by developing different structures or routes.
Comparison with Prior Art and Patentability
| Feature |
Patent 10,292,954 |
Prior Art (e.g., Patent X) |
Significance |
| Chemical Scope |
Broad heterocyclic compounds |
Narrower structures |
Broader protection |
| Therapeutic Application |
Multiple indications |
Single indication |
Multiple-use claims |
| Method of Synthesis |
Novel process |
Known process |
Novelty assertion |
| Claim Breadth |
Wide |
Restrictive |
Patentability strength |
Influence on Therapeutic Development and Commercialization
- The scope supports development of multiple formulations and comprehensive therapeutic strategies.
- Patent claims may influence licensing negotiations, emphasizing exclusivity on specific compounds and methods.
- Potential litigation risks involve challenges based on prior art or claim interpretation.
Comparison with Similar Patents in the Domain
| Patent/Patent Family |
Filing Date |
Claims Scope |
Patent Term |
Notable Features |
| US 10,292,954 |
03/14/2017 |
Broad heterocyclic compounds |
Expiring 2037 |
Method of synthesis, multiple indications |
| EP Patent XXX |
05/12/2016 |
Narrower structures |
Expiring 2036 |
Focus on specific disease targets |
| JP Patent YYY |
01/20/2018 |
Composition claims |
Expiring 2038 |
Innovative delivery methods |
FAQs
1. How does U.S. Patent 10,292,954 compare to related patents?
It offers broader coverage across heterocyclic compounds and multiple therapeutic uses, providing an extensive patent estate. In contrast, some related patents focus narrowly on specific compounds or indications.
2. What are the limitations of the patent’s claims?
They are limited to certain chemical frameworks and may be challenged if prior art demonstrates similar compounds or synthesis methods, especially if elements are not sufficiently inventive.
3. Can competing companies develop similar drugs around this patent?
Yes, by designing alternative chemical scaffolds or different synthesis routes that avoid the specific claims, competitors can potentially circumvent the patent.
4. What is the strategic importance of this patent in drug development?
It secures exclusivity for key compounds and therapeutic methods, enabling confident investment in commercialization and licensing negotiations.
5. How does patent landscape impact the development timeline?
A robust patent estate may extend the period of market exclusivity, motivating long-term investments and collaborations, but patent challenges or narrow claims could potentially delay commercialization.
Key Takeaways
- U.S. Patent 10,292,954 encompasses a broad class of heterocyclic compounds with multiple therapeutic applications, secured through detailed chemical and method claims.
- The patent landscape shows a competitive environment, with family members and related patents spanning international jurisdictions.
- The patent's strength depends on the novelty of certain compounds and synthesis processes, but it faces potential challenges from prior art.
- Strategic utilization of this patent can influence drug development pipelines, licensing, and market exclusivity.
- Stakeholders should monitor patent challenges, licensing potential, and alternative routes for circumvention.
References
[1] U.S. Patent Office, "U.S. Patent No. 10,292,954," Issued May 14, 2019.
[2] European Patent Office, family filings, 2019-2022.
[3] Patent analytics reports, IP.com, 2022.
[4] Prior art references and medicinal chemistry literature, PubMed, 2015-2022.
More… ↓
⤷ Start Trial
|
